Lightning up the vaccine discovery process
We help companies optimise their vaccines' antigenicity and immunogenicity by analysing millions of genomes of viruses and immunological and epidemiological data.
We help companies optimise their vaccines' antigenicity and immunogenicity by analysing millions of genomes of viruses and immunological and epidemiological data.
Our mission is to accelerate vaccine discovery with AI. We provide the technology and Machine Learning models that accelerate the drug development process and increase vaccine efficacy against current and future variants of the viruses. We want to fully unlock the potential of mRNA by optimising the drug development pipeline and automating the process of finding vaccine candidates.
We started Deepflare with the goal of analysing genomes of SARS-CoV-2 and helping to develop. To achieve that, we developed an AI platform that analyses millions of viruses, predicts future variants, and quickly finds sequences to contain in a drug and vaccine.
Deepflare can be used to:
